readthroughSign in
CompanyCHRSNasdaqRedwood City, CA

Coherus Oncology, Inc.

Coherus Oncology is a commercial-stage oncology company developing the PD-1 inhibitor toripalimab and a pipeline of antibody immunotherapies targeting liver, head and neck, colorectal, and gastrointestinal cancers.

8-KNov 12Latest SEC filing
Nov 9Latest story